Condition

PSMA PET clinical trials and research

As of November 12, 2026, Find a Trial lists 4 PSMA PET clinical trials that are recruiting, in China. Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.

Newest PSMA PET clinical trials

StudyPhaseWhereStatusRegistered
Repeated PSMA PET scans to monitor treatment response in clinically significant prostate cancer. — Lanzhou, Gansu and 8 other locations Recruiting Apr 28, 2026
Blood exosomal RNA test to rule out prostate cancer spread to bone — Lanzhou, Gansu and 8 other locations Recruiting Apr 28, 2026
PSMA PET/MRI-guided prostate biopsy for men with prior negative biopsies and low PI-RADS — Fuzhou, Fujian Recruiting Apr 11, 2025
Evaluating 68Ga-PSMA PET for advanced renal cancer diagnosis — Lanzhou, Gansu and 8 other locations Recruiting Aug 3, 2021

All recruiting trials (4)

Related topics

High-risk Prostate CancerLiquid BiopsyMetastasesProstate Cancer (Diagnosis)Prostate Cancer ScreeningRenal CancerTreatment Response

Quick answers

How many PSMA PET clinical trials are recruiting right now?

4, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

All of them have sites in China. Each study page lists its sites and which ones are recruiting.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →

Last reviewed 2026-11-12 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.